Merck announced it is cutting 500 jobs in several states.
In a statement the company said that the Worker Adjustment and Retraining Notification (WARN) it received on Wednesday is in regard to several changes in its U.S. commercial organization.
“Approximately 500 people will be affected in select sales and headquarters commercial teams. The roles being eliminated are located across all states; but for administrative purposes, the jobs are associated with Merck’s U.S. [Human Health and Merck Research Laboratories] headquarters in Upper Gwynedd, Pa. Employees whose jobs are impacted by these changes can apply to other open positions at Merck,” according to the released statement.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!
Impacted employees who are not placed in a role will be offered a comprehensive separation package and will separate from Merck on Jan. 3, 2020.
“This is not a new restructuring effort; these changes are part of ongoing company-wide efforts to sharpen Merck’s focus on innovative research and development that addresses significant unmet medical needs and on our best opportunities for growth,” according to the statement.